We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Uniphar plc (UPR) ORD EUR0.08

Sell:260.00p Buy:270.00p 0 Change: No change
FTSE AIM 100:1.61%
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:260.00p
Buy:270.00p
Change: No change
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:260.00p
Buy:270.00p
Change: No change
Market closed Prices as at close on 24 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • Uniphar posts strong profit growth for 2021

    1 March 2022 11:37

    (Sharecast News) - Healthcare service provider Uniphar reported a 26.3% improvement in gross profit in its preliminary results on Tuesday to €274.5m (£228.54m), or 8.5% on an organic basis.

  • Uniphar ends year with lower-than-expected debt levels

    26 January 2022 15:37

    (Sharecast News) - Healthcare services company Uniphar said in a trading update on Wednesday that it performed in line with its own expectations for 2021, at both a gross profit and EBITDA level, with strong...

  • Uniphar makes three pharma sector acquisitions

    23 December 2021 10:00

    (Sharecast News) - Uniphar announced the acquisitions of UK-based brand commercialisation and pharmaceutical marketing agency E4H, UK-based pharmaceutical distributor Devonshire Healthcare Services, and...

  • Uniphar posts strong first-half growth

    1 September 2021 09:20

    (Sharecast News) - Healthcare services provider Uniphar reported gross profit growth of 30.9% in its first half on Wednesday to €134.29m (£115.25m), or 11.2% on an organic basis.

  • Uniphar acquires US medical affairs services business

    2 August 2021 10:24

    (Sharecast News) - Healthcare firm Uniphar has acquired New York-based medical affairs services provider BESTMSLs for an undisclosed price.

  • Uniphar reports strong first-half momentum

    27 July 2021 14:03

    (Sharecast News) - Pharmaceutical and medical technology service provider Uniphar said in a trading update on Tuesday that strong momentum had continued throughout its first half.

  • Uniphar acquires Germany-based CoRRect Medical

    20 July 2021 09:48

    (Sharecast News) - Uniphar announced the acquisition of CoRRect Medical on Tuesday, which it described as a Germany-based company that specialises in the commercialisation and distribution of medical device...

  • Momentum continues into new year for Uniphar

    12 May 2021 10:15

    (Sharecast News) - Healthcare services company Uniphar updated the market on its trading on Wednesday, having outperformed expectations in its final results for 2020.

  • Uniphar ends year 'strong' as core divisions outperform

    2 March 2021 12:29

    (Sharecast News) - Healthcare services company Uniphar reported a "strong" 2020 in its preliminary results on Tuesday, with return on capital employed increasing to 18.9%, from 17.3% in 2019.

  • Uniphar performs ahead of FY expectations

    27 January 2021 08:43

    (Sharecast News) - Healthcare services business Uniphar said on Wednesday that it had performed ahead of full-year expectations at both a gross profit and underlying earnings level in 2020, with high free...

  • Uniphar acquires US pharmaceutical advisory business

    24 November 2020 08:30

    (Sharecast News) - Diversified healthcare services group Uniphar has acquired Maryland-based pharmaceutical advisory business RRD.

  • Uniphar acquires Diligent Health Solutions in $27m deal

    23 September 2020 12:58

    (Sharecast News) - Uniphar announced the acquisition of the US-based Diligent Health Solutions on Wednesday, in a deal worth up to $27m (£21.21m).

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2022. All rights reserved.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.